Skip to main content
. 2022 Sep 26;10(10):1613. doi: 10.3390/vaccines10101613

Figure 3.

Figure 3

ELISA-based surrogate neutralization against Omicron BA2 variant in response to the CoronaVac/ChAdOx1/mRNA versus the ChAdOx1/ChAdOx1/mRNA vaccination in cancer patients. Data are reported as the median and 95%CI of percentage of inhibition between human ACE-2 and RBD protein. The cut-off value of 30% indicates the presence of detectable neutralization according to the manufacturer’s (cPass, Genscript) protocol. Data points represent individual samples. The pink color represents chemotherapy and the blue color represents treatment with hormonal therapy/biologics. a Mann-Whitney test.